Skip to main content
Singapore Clinical Research Institute will NEVER ask you to transfer money or disclose bank details over a call.

If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg (opens in new tab).

Singapore Clinical Research Institute (SCRI)

Current Trials

Find out more about the ongoing trials we are participating in

Last updated on 20 August 2026

AHCC 11

Track micro-RNA changes in liver cancer patients after surgery through the PROSECT study, now in follow-up and data analysis after completing recruitment.

AHCC09

Find out about the STRATUM trial (AHCC09), a Phase II study testing SIRT-Y90 combined with atezolizumab and bevacizumab in patients with locally advanced liver cancer.

AHCC10

Find out about the ELEGANCE study, which tracks biomarkers in patients at high risk of liver cancer. Recruitment of 2,002 subjects has been completed, with follow-up and data analysis now under way.

AHCC14

Explore the RE-BALANCE study, which aims to prevent liver cancer by restoring bile acid balance through lifestyle changes, recruiting 90 patients from the AHCC10 ELEGANCE cohort.

PLANet 2'0 AHCC12 and AHCC13

Find out about the PLANet 2.0 study, which uses precision medicine to improve liver cancer treatment across the Asia-Pacific region.